Tjerignimin Adissa Silue joined the National Institute of Health in October, 2020 after completing her Ph.D in Bioengineering from George Mason University and acquiring her Biotechnology Management Certificate from Harvard University. Prior to that she had the opportunity to work as a Regulatory Affairs Lead at the Jockey Rehabilitation Center in Hong Kong, and a Scientist at NIDA, NIH and CDRH, FDA where she worked on drug development for neurological disorders and on neurological devices respectively. She has experience in biomarkers, neurological, translational devices, stroke clinical data and project management with a strong clinical, scientific background, and analytical expertise.
CONTRACTOR - OTHER
Division of Translational Research